Daniel S. Levine

Daniel S. Levine is editor of Rare Daily. You can contact him by sending email to editor@globalgenes.org

Orchard Therapeutics to Build-out New Gene Therapy Manufacturing Facility in California
Rare Daily Staff Gene therapy developer Orchard Therapeutics said it signed a long-term lease agreement to build-out a gene therapy… Continue Reading
Biogen Ends AGTC Collaboration After Data from Gene Therapy Study in Retinoschisis Shows No Sign of Clinical Activity
Rare Daily Staff Applied Genetic Technologies Corporation said Biogen terminated its collaboration after it reported topline interim data… Continue Reading
Late-Stage Trial Underway for Treatment of Rare Obesity Disorder
Prader-Willi syndrome is a rare genetic disease with many effects, but it is characterized by an insatiable drive to eat that leads to… Continue Reading
Aeglea BioTherapeutics Readies to Begin Pivotal Phase 3 in Arginase 1 Deficiency
Rare Daily Staff Aeglea BioTherapeutics said after discussions with regulators in the United States and Europe, it plans to conduct a single… Continue Reading
Gilbert Family Foundation Announces $12 Million Gene Therapy Initiative in NF1
Rare Daily Staff The Gilbert Family Foundation, a private foundation established by Jennifer and Dan Gilbert, said it has launched a $12… Continue Reading
Rare Leader: Deanna Portero, Executive Director, Fibrous Dysplasia Foundation
The Basics Name:   Deanna Portero Title:   Executive Director Organization: Fibrous Dysplasia Foundation Disease focus:   Fibrous… Continue Reading
Georgia Ehlers-Danlos Syndrome Network Partners with Backpack Health to Provide Health Management Tool
Rare Daily Staff The Georgia Ehlers-Danlos Syndrome Network has partnered with Backpack Health to provide a free tool to help individuals,… Continue Reading

Follow us on Twitter